These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13869229)

  • 1. [Heparin test in hyperlipemia and its practical value].
    BINAK K; HARMANCI N
    Turk Tip Cemiy Mecm; 1961 Oct; 27():499-507. PubMed ID: 13869229
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective lipemia clearing response to heparin in idiopathic hyperlipemia.
    KLEIN E; LEVER WF; FEKETE LL
    J Invest Dermatol; 1959 Sep; 33():91-7. PubMed ID: 14409662
    [No Abstract]   [Full Text] [Related]  

  • 3. Rebound hyperlipemia following intravenous heparin.
    WOLDOW A; WOLF HL
    Am J Cardiol; 1960 Dec; 6():1036-41. PubMed ID: 13786247
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of heparin on alimentary hyperlipemia. Two-dimensional electrochromatographic study.
    BENAS A; KELER-BACOKA M; PUCAR Z
    Arch Biochem Biophys; 1962 Feb; 96():434-7. PubMed ID: 13867025
    [No Abstract]   [Full Text] [Related]  

  • 5. Demonstration of lipoprotein lipase activity (free fatty acid release) by in vitro sonic oscillation (sonation) of post-heparin plasma from subjects with "heparin-unresponsive" hyperglyceridemia (hyperlipemia).
    FURMAN RH; ROBINSON CW
    Trans Am Clin Climatol Assoc; 1961; 73():30-8. PubMed ID: 13895954
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. III. Effects of intravenously administered heparin on the plasma proteins and lipids.
    LEVER WF; SMITH PA; HURLEY NA
    J Invest Dermatol; 1954 Jan; 22(1):71-84; discussion, 84-7. PubMed ID: 13118255
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECT OF MULTIPLE INJECTIONS OF HEPARIN ON THE HYPERLIPEMIA OF ATHEROSCLEROSIS.
    WOLDOW A; LOPEZ RH; GOLDBERG H
    Am J Cardiol; 1964 Jul; 14():64-8. PubMed ID: 14176893
    [No Abstract]   [Full Text] [Related]  

  • 8. Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. VIII. Effects of protamine on the electrophoretic and ultracentrifugal changes produced in the serum by heparin.
    LEVER WF; LYONS ME
    J Invest Dermatol; 1956 Nov; 27(5):325-34. PubMed ID: 13385540
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of heparin on plasma lipid partition in man: studies in normal persons and in patients with coronary atherosclerosis, nephrosis and primary hyperlipemia.
    HERZSTEIN J; WANG CI; ALDERSBERG D
    Ann Intern Med; 1954 Feb; 40(2):290-305. PubMed ID: 13125213
    [No Abstract]   [Full Text] [Related]  

  • 10. Idiopathic hyperlipemia and primary hypercholesteremic xanthomatosis. VI. Studies of the serum proteins and lipoproteins by moving boundary electrophoresis and paper electrophoresis before and after administration of heparin.
    HERBST FS; LEVER WF; HURLEY NA
    J Invest Dermatol; 1955 May; 24(5):507-25. PubMed ID: 14381667
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of hyperlipemia & certain clearing factors on erythrosedimentation rate in autoplasma & in pectin in atherosclerotic subjects].
    RULLI V; ROSSI B
    Gazz Med Ital; 1959 May; 118(5):207-10. PubMed ID: 13664061
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE BIOLOGICAL SYNDROME OF ARTERIOSCLEROSIS AND ITS CLINICAL VALUE].
    DE BETTENCOURT JM
    J Soc Cienc Med Lisb; 1963 Mar; 127():155-79. PubMed ID: 14113565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on experimental hyperlipemia. IV. Effects of heparin on the inhibitor of the clarifying factor].
    Jouzier E; Tixier M; Tayeau F
    Bord Med; 1970 Sep; 3(9):2017-20. PubMed ID: 5481185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of heparin on blood lipids under conditions of endo- and exogenous hyperlipemia].
    Lipovetskiĭ BM; Ryzhov VM
    Kardiologiia; 1976 Mar; 16(3):123-7. PubMed ID: 191678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipemia clearing effect of buccally administered heparin potassium (clarin).
    HIRSHLEIFER I; NAYAK R
    Am J Med Sci; 1961 May; 241():645-9. PubMed ID: 13714632
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublingual heparin in hyperlipemia; a preliminary report.
    FULLER HL
    Angiology; 1958 Oct; 9(5):311-3. PubMed ID: 13583625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of the lipoid fractions in alimentary lipemia by administration of heparin with special reference to unsaturated fatty acids. IV].
    KRAUTWALD A; LINKE H; WEIGEL W
    Acta Biol Med Ger; 1959; 3():114-23. PubMed ID: 14411820
    [No Abstract]   [Full Text] [Related]  

  • 18. Demonstration of lipemia-clearing activity after sublingual administration of heparin potassium in the rabbit.
    MANGIERI CN; CAIN RA
    Angiology; 1961 Apr; 12():136-8. PubMed ID: 13766149
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential hyperlipemia treated with heparin and with chlorpromazine.
    HOLLISTER LE; KANTER SL
    Gastroenterology; 1955 Dec; 29(6):1069-76. PubMed ID: 13270832
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial blood flow and oxygen consumption during postprandial lipemia and heparin-induced lipolysis.
    REGAN TJ; BINAK K; GORDON S; DEFAZIO V; HELLEMS HK
    Circulation; 1961 Jan; 23():55-63. PubMed ID: 13740345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.